Literature DB >> 28013382

Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.

Andrew F Malone1, Steven D Funk1, Tarek Alhamad1, Jeffrey H Miner2.   

Abstract

BACKGROUND: Many COL4A5 splice region variants have been described in patients with X-linked Alport syndrome, but few have been confirmed by functional analysis to actually cause defective splicing. We sought to demonstrate that a novel COL4A5 splice region variant in a family with Alport syndrome is pathogenic using functional studies. We also describe an alternative method of diagnosis.
METHODS: Targeted next-generation sequencing results of an individual with Alport syndrome were analyzed and the results confirmed by Sanger sequencing in family members. A splicing reporter minigene assay was used to examine the variant's effect on splicing in transfected cells. Plucked hair follicles from patients and controls were examined for collagen IV proteins using immunofluorescence microscopy.
RESULTS: A novel splice region mutation in COL4A5, c.1780-6T>G, was identified and segregated with disease in this family. This variant caused frequent skipping of exon 25, resulting in a frameshift and truncation of collagen α5(IV) protein. We also developed and validated a new approach to characterize the expression of collagen α5(IV) protein in the basement membranes of plucked hair follicles. Using this approach we demonstrated reduced collagen α5(IV) protein in affected male and female individuals in this family, supporting frequent failure of normal splicing.
CONCLUSIONS: Differing normal to abnormal transcript ratios in affected individuals carrying splice region variants may contribute to variable disease severity observed in Alport families. Examination of plucked hair follicles in suspected X-linked Alport syndrome patients may offer a less invasive alternative method of diagnosis and serve as a pathogenicity test for COL4A5 variants of uncertain significance.

Entities:  

Keywords:  Alport syndrome; COL4A5; Hair follicle; Immunofluorescence; Splice site mutation

Mesh:

Substances:

Year:  2016        PMID: 28013382      PMCID: PMC5400701          DOI: 10.1007/s00467-016-3565-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome patients carrying missense mutations in the collagenous domain of COL4A5.

Authors:  D Tsiakkis; M Pieri; P Koupepidou; P Demosthenous; K Panayidou; C Deltas
Journal:  Clin Genet       Date:  2012-02-16       Impact factor: 4.438

Review 2.  Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants.

Authors:  Pascaline Gaildrat; Audrey Killian; Alexandra Martins; Isabelle Tournier; Thierry Frébourg; Mario Tosi
Journal:  Methods Mol Biol       Date:  2010

3.  A Custom Targeted Next-Generation Sequencing Gene Panel for the Diagnosis of Genetic Nephropathies.

Authors:  Christopher P Larsen; Tim Durfee; Jon D Wilson; Marjorie L Beggs
Journal:  Am J Kidney Dis       Date:  2016-01-12       Impact factor: 8.860

Review 4.  Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.

Authors:  C E Kashtan
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

5.  The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes.

Authors:  D B Borza; O Bondar; Y Ninomiya; Y Sado; I Naito; P Todd; B G Hudson
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

6.  X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5.

Authors:  P Demosthenous; K Voskarides; K Stylianou; M Hadjigavriel; M Arsali; C Patsias; E Georgaki; P Zirogiannis; C Stavrou; E Daphnis; A Pierides; C Deltas
Journal:  Clin Genet       Date:  2011-03-13       Impact factor: 4.438

Review 7.  Molecular genetics of Alport syndrome.

Authors:  K Tryggvason; J Zhou; S L Hostikka; T B Shows
Journal:  Kidney Int       Date:  1993-01       Impact factor: 10.612

8.  Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.

Authors:  C Bonnet; S Krieger; M Vezain; A Rousselin; I Tournier; A Martins; P Berthet; A Chevrier; C Dugast; V Layet; A Rossi; R Lidereau; T Frébourg; A Hardouin; M Tosi
Journal:  J Med Genet       Date:  2008-04-18       Impact factor: 6.318

9.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

10.  Alport Syndrome in Women and Girls.

Authors:  Judy Savige; Deb Colville; Michelle Rheault; Susie Gear; Rachel Lennon; Sharon Lagas; Moira Finlay; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 8.237

View more
  10 in total

1.  Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

Authors:  Tomoko Horinouchi; Kandai Nozu; Tomohiko Yamamura; Shogo Minamikawa; Takashi Omori; Keita Nakanishi; Junya Fujimura; Akira Ashida; Mineaki Kitamura; Mitsuhiro Kawano; Wataru Shimabukuro; Chizuko Kitabayashi; Aya Imafuku; Keiichi Tamagaki; Koichi Kamei; Kenjirou Okamoto; Shuichiro Fujinaga; Masafumi Oka; Toru Igarashi; Akinori Miyazono; Emi Sawanobori; Rika Fujimaru; Koichi Nakanishi; Yuko Shima; Masafumi Matsuo; Ming Juan Ye; Yoshimi Nozu; Naoya Morisada; Hiroshi Kaito; Kazumoto Iijima
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

2.  Evaluation of Suspected Autosomal Alport Syndrome Synonymous Variants.

Authors:  Rini Rossanti; Tomoko Horinouchi; Tomohiko Yamamura; China Nagano; Nana Sakakibara; Shinya Ishiko; Yuya Aoto; Atsushi Kondo; Sadayuki Nagai; Eri Okada; Shingo Ishimori; Hiroaki Nagase; Satoshi Matsui; Keiichi Tamagaki; Yoshifumi Ubara; Masahiko Nagahama; Yuko Shima; Koichi Nakanishi; Takeshi Ninchoji; Masafumi Matsuo; Kazumoto Iijima; Kandai Nozu
Journal:  Kidney360       Date:  2021-10-13

3.  Functional splicing analysis in an infantile case of atypical hemolytic uremic syndrome caused by digenic mutations in C3 and MCP genes.

Authors:  Tomohiko Yamamura; Kandai Nozu; Hiroaki Ueda; Rika Fujimaru; Ryutaro Hisatomi; Yoko Yoshida; Hideki Kato; Masaomi Nangaku; Toshiyuki Miyata; Toshihiro Sawai; Shogo Minamikawa; Hiroshi Kaito; Masafumi Matsuo; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

Review 4.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

5.  An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis.

Authors:  Tomohiko Yamamura; Kandai Nozu; Yuya Miyoshi; Keita Nakanishi; Junya Fujimura; Tomoko Horinouchi; Shogo Minamikawa; Nobuo Mori; Rika Fujimaru; Koichi Nakanishi; Takeshi Ninchoji; Hiroshi Kaito; Taniguchi-Ikeda Mariko; Ichiro Morioka; Masafumi Matsuo; Kazumoto Iijima
Journal:  BMC Nephrol       Date:  2017-12-04       Impact factor: 2.388

6.  Functional assessment of a novel COL4A5 splicing site variant in a Chinese X-linked Alport syndrome family.

Authors:  Xiaolei Chen; Nan Ye; Lu Zhang; Wen Zheng; Jingqiu Cheng; Meng Gong
Journal:  Ann Transl Med       Date:  2021-09

Review 7.  The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome.

Authors:  Tomohiko Yamamura; Tomoko Horinouchi; Yuya Aoto; Rachel Lennon; Kandai Nozu
Journal:  Front Med (Lausanne)       Date:  2022-02-08

8.  Identification of Four Novel COL4A5 Variants and Detection of Splicing Abnormalities in Three Chinese X-Linked Alport Syndrome Families.

Authors:  Sai Wang; Yingfei Shao; Yixiu Wang; Jingru Lu; Leping Shao
Journal:  Front Genet       Date:  2022-03-17       Impact factor: 4.599

9.  Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.

Authors:  Tomoko Horinouchi; Tomohiko Yamamura; Shogo Minamikawa; China Nagano; Nana Sakakibara; Koichi Nakanishi; Yuko Shima; Naoya Morisada; Shinya Ishiko; Yuya Aoto; Hiroaki Nagase; Hiroki Takeda; Rini Rossanti; Shingo Ishimori; Hiroshi Kaito; Masafumi Matsuo; Kazumoto Iijima; Kandai Nozu
Journal:  Mol Genet Genomic Med       Date:  2020-06-16       Impact factor: 2.183

Review 10.  Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.

Authors:  Kandai Nozu; Yutaka Takaoka; Hirofumi Kai; Minoru Takasato; Kensuke Yabuuchi; Tomohiko Yamamura; Tomoko Horinouchi; Nana Sakakibara; Takeshi Ninchoji; China Nagano; Kazumoto Iijima
Journal:  Kidney Res Clin Pract       Date:  2020-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.